The inquiry letter mentioned that Lexin medical said on the interactive platform that the company will continue to explore the application scenarios, business models, software and hardware solutions of new technologies such as blockchain technology in the field of health, and Shenzhen Stock Exchange asked listed companies to explain whether they would take the initiative to cater to the market hot spots and hype the companys share price.
At present, Lexin medical is mainly engaged in the research, production and marketing of household medical and health electronic products, cloud platform operation, etc. The main products are wearable sports bracelet watch, electronic health scale, electronic sphygmomanometer, etc.
Lexin medical disclosed a notice on the establishment of blockchain research laboratory on March 19 last year. At that time, the company said that it had jointly set up a research laboratory with BCK cloud (Beijing) blockchain Technology Co., Ltd. The laboratory will aim at the key innovative technologies with strategic significance in the field of chronic disease, sports and health management, gather various related resources, promote the application and landing of blockchain technology in the field of chronic disease, sports and health management, and promote the research, development and transformation of intelligent wearable devices and medical devices under the blockchain technology.
For details of Lexin medicals blockchain technology layout, the reporter of daily economic news also interviewed the Securities Department of listed companies, but the other side said: the specific situation will be explained in the reply announcement later..
Multiple companies receive inquiries
As a new generation of revolutionary technology after the mobile Internet, blockchain can effectively reduce the cost of individual trust and improve the efficiency of production with its distributed storage, decentralization, tamperability and other characteristics.
In the medical field, due to the characteristics of complex system and too scattered medical data in some industries, the traceability, data storage and statistical ability of blockchain technology are expected to help the pharmaceutical industry solve some pain points. At present, many international pharmaceutical giants are interested in blockchain technology.
According to the article published by arteria.com on 36 krypton, in May 2017, a number of pharmaceutical enterprises led by Pfizer announced the launch of relevant projects, in order to create a blockchain tool to manage the drug supply chain, so that pharmaceutical manufacturers, wholesalers, etc. can use the blockchain to register and trace the drug information. Novartis has been exploring the wide application of blockchain technology in counterfeit drug detection, supply chain, patient data and clinical trials since 2016.
Although blockchain seems to have many advantages, many listed companies have not cultivated a practical business, let alone a mature model to achieve profitability. However, these can not prevent some listed companies from joining the enthusiasm of blockchain voice group through announcement, interactive platform and other channels.
The exchange also paid attention to the listed companies that announced the intention of blockchain layout. On October 28 and 29, several companies received the notice letter or inquiry letter from the exchange.
Source: editor in charge of daily economic news: Yang bin_nf4368